Microencapsulation techniques in HIV pediatric formulations: advances and future outlook

Simple item page
dc.contributor.authorOkafor, Nnamdi Ikemefuna
dc.date.accessioned2025-01-21T12:09:04Z
dc.date.available2025-01-21T12:09:04Z
dc.date.issued2024
dc.description.abstractThe treatment of human immunodeficiency virus (HIV) in children has persistently been complex and tedious on a global scale. This is because adult and pediatric HIV treatments follow a similar therapeutic approach. Due to the dearth of clinically licensed pediatric antiretroviral drug (ARVD) therapy, children with HIV worldwide are prescribed unlicensed drugs each year. This has triggered likelihood of poor drug adherence, therapeutic failure, and even adverse reactions brought on by a variety of factors, including pill size and quantity, which is the main cause of swallowing difficulties, repeated administration of these various ARVDs, many of which have poor solubility and cause severe side effects in children, and unpalatability of the drug, which is one of the criteria for pediatric formulations. Thus, there is a necessity for investigation into several advanced microencapsulation techniques that could curb these challenges. Microencapsulation techniques have explored in drug delivery for encapsulation and manufacture of different nanoparticles that have shown significant potential in mitigating and surmounting different constraints, such as taste masking, enhanced drug solubility and bioavailability, and production of micronized fine powders for treatment of varying diseases. Nevertheless, the usage of these technologies in HIV pediatric formulations has garnered relatively little attention.
dc.identifier.citationOkafor, N.I., 2024. Microencapsulation Techniques in HIV Pediatric Formulations: Advances and Future Outlook. Advances in Pharmacological and Pharmaceutical Sciences, 2024(1), p.5081655.
dc.identifier.urihttps://doi.org/10.1155/2024/5081655
dc.identifier.urihttps://hdl.handle.net/10566/19872
dc.language.isoen
dc.publisherJohn Wiley and Sons Ltd
dc.subjectBioavailability
dc.subjectDrug delivery system
dc.subjectDrug solubility
dc.subjectSide effect
dc.subjectUnlicensed drug use
dc.titleMicroencapsulation techniques in HIV pediatric formulations: advances and future outlook
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
okafor_microencapsulation_techniques_in_hiv_pediatric_2024.pdf
Size:
3.35 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Research Articles (School of Pharmacy)